The legalisation of cannabis is one of the most frequently debated topics of our time.
Products like CBD oil, also known as cannabis oil or cannabidiol, have soared in popularity. According to the Cannabis Trades Association UK, the number of cannabidiol consumers have doubled from 125,000 in 2017 to 250,000 in 2018.
Sativa Investments (NXT:SATI) seeks to invest in companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.